Skip to main content

Table 1 Characteristics of the study subjects

From: Influences of changes in obesity-related parameters on progression of arteriosclerosis in hemodialysis patients: a prospective cohort study

Number of patients 258
Age (years) 67.4 ± 12.1
Gender (m/f) 146/112
Body mass index (kg/m2) 22.2 ± 3.7
Dialysis history (months) 63.2 ± 55.4
Diabetes (%) 123 (47.7)
Hyperlipidemia drugs (%) 35 (13.6)
Systolic BP (mmHg) 152 ± 22
Diastolic BP (mmHg) 76 ± 14
Laboratory study
 Hemoglobin (g/dl) 10.8 ± 1.0
 High-density lipoprotein cholesterol (mg/dl) 46.8 ± 14.6
 Low-density lipoprotein cholesterol (mg/dl) 88.7 ± 29.4
 Triglyceride (mg/dl) 103.2 ± 65.5
 Uric acid (mg/dl) 7.2 ± 1.3
 Creatinine (mg/dl) 9.6 ± 2.5
 C-reactive protein (mg/dl) 0.34 ± 0.70
 Ca (mg/dl) 8.9 ± 0.5
 Inorganic phosphorus (mg/dl) 5.2 ± 1.2
 Intact-parathyroid hormone (pg/ml) 143.4 ± 85.0
 Albumin (g/dl) 3.7 ± 0.3
 Hemoglobin A1c (%) 5.34 ± 0.85
 Human atrial natriuretic polypeptide (pg/ml) 69.3 ± 107.9
 Brain natriuretic peptide (pg/ml) 264.5 ± 404.1
Cardiothoracic ratio (%) 52.3 ± 5.3
Brachial-ankle pulse wave velocity (cm/s) 2041 ± 654
Abdominal circumference (cm) 83.5 ± 10.3
Visceral fat area (cm2) 84.7 ± 59.2
Subcutaneous fat area (cm2) 118.2 ± 73.0
  1. Values are expressed as mean ± SD